FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:1638-1639 June 15, 1995 Number 24 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Thanks to many public health advances, in the developed countries the average woman will be postmenopausal for about one third of her life. As a consequence, she and her physician will ultimately need to make a decision about postmenopausal estrogen-replacement therapy. This treatment has been used for several decades, but there is a surprising lack of consensus about when and how to use it. The initial goal of estrogen-replacement therapy was to alleviate menopausal symptoms. More recently, the possibility has emerged that estrogen can reduce morbidity and mortality from ischemic heart disease and osteoporosis. However, women and their physicians must . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Allred, K. F., Smart, E. J., Wilson, M. E. (2006). Estrogen Receptor-{alpha} Mediates Gender Differences in Atherosclerosis Induced by HIV Protease Inhibitors. J. Biol. Chem. 281: 1419-1425 [Abstract] [Full Text]  
• Rodriguez, C., Patel, A. V., Calle, E. E., Jacob, E. J., Thun, M. J. (2001). Estrogen Replacement Therapy and Ovarian Cancer Mortality in a Large Prospective Study of US Women. JAMA 285: 1460-1465 [Abstract] [Full Text]  
• (1998). Treatment of Estrogen Deficiency Symptoms in Women Surviving Breast Cancer. J. Clin. Endocrinol. Metab. 83: 1993-2000 [Full Text]  
• Meunier, P. J., Confavreux, E., Tupinon, I., Hardouin, C., Delmas, P. D., Balena, R. (1997). Prevention of Early Postmenopausal Bone Loss with Cyclical Etidronate Therapy (A Double-Blind, Placebo-Controlled Study and 1-Year Follow-Up). J. Clin. Endocrinol. Metab. 82: 2784-2791 [Abstract] [Full Text]